US Stock MarketDetailed Quotes

ADAP Adaptimmune Therapeutics

Watchlist
  • 1.075
  • +0.015+1.42%
Close Apr 26 16:00 ET
  • 1.090
  • +0.015+1.40%
Post 19:36 ET
274.73MMarket Cap-1990P/E (TTM)

Adaptimmune Therapeutics Key Stats

Adaptimmune Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Mar 6, 2024

Revenue(YoY)

231.00K

-97.91%
EPS(YoY)

-0.18

0.00%

Buy

Apr 27, 2024

Adaptimmune Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 25.672M--
--2024/Q1-- / 20.480M--
Mar 6, 20242023/Q4231.000K / 25.960M--
Nov 8, 20232023/Q37.319M / 15.140M--
Aug 9, 20232023/Q25.130M / 6.675M--
May 12, 20232023/Q147.601M / ----
Mar 6, 20232022/Q411.028M / 5.083M--
Nov 8, 20222022/Q37.007M / 5.000M--
Aug 4, 20222022/Q25.538M / 10.100M--
May 9, 20222022/Q13.575M / 5.000M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 25.672M--
--2024/Q1-- / 20.480M--
Mar 6, 20242023/Q4231.000K / 25.960M--
Nov 8, 20232023/Q37.319M / 15.140M--
Aug 9, 20232023/Q25.130M / 6.675M--
May 12, 20232023/Q147.601M / ----
Mar 6, 20232022/Q411.028M / 5.083M--
Nov 8, 20222022/Q37.007M / 5.000M--
Aug 4, 20222022/Q25.538M / 10.100M--
May 9, 20222022/Q13.575M / 5.000M--

Unlock Free Earnings Estimates

Adaptimmune Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 27, 2024

Buy

  • Buy

    57.14%
  • Hold

    28.57%
  • Sell

    14.29%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg